<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001591</url>
  </required_header>
  <id_info>
    <org_study_id>970152</org_study_id>
    <secondary_id>97-CC-0152</secondary_id>
    <nct_id>NCT00001591</nct_id>
  </id_info>
  <brief_title>Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy</brief_title>
  <official_title>Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institutes of Health Clinical Center (CC)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Technical advances in magnetic resonance imaging (MRI) and magnetic resonance spectroscopy&#xD;
      (MRS) have provided researchers with the opportunity to study changes of the central nervous&#xD;
      system (CNS) and improve diagnosis and therapy of CNS disease. New MRI and MRS techniques&#xD;
      specifically designed for functional MRI (fMRI) and MRS imaging of the CNS will be evaluated&#xD;
      in normal volunteers and in patients with CNS diseases. This study will develop and evaluate&#xD;
      new magnetic resonance pulse sequences for performing MRI or MRS and compare the results to&#xD;
      existing MR techniques.&#xD;
&#xD;
      Patients and volunteers age 18 and older are eligible for the study. A history will be taken&#xD;
      in which exclusion criteria (such as having a pacemaker or cochlear implants) will be&#xD;
      addressed, and a pregnancy test will be administered to women of childbearing age. Each&#xD;
      subject will also be asked to fill out a questionnaire.&#xD;
&#xD;
      Study participants will lie in the MRI scanner from 20 minutes to 2 hours. A coil may be&#xD;
      placed on the head and participants may be asked to do simple or complex tasks. A catheter&#xD;
      will be placed in an arm vein and a contrast agent will be administered. This agent will&#xD;
      allow structures in the brain to show up more clearly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Technical advances in Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy&#xD;
      (MRS) have provided researchers with the opportunity to study functional and metabolic&#xD;
      changes of the central nervous system (CNS) in both normal individuals and individuals with&#xD;
      neurological diseases in response to sensory, motor or cognitive stimulation. New MRI and MRS&#xD;
      techniques specifically designed for Functional Magnetic Resonance Imaging (fMRI) and&#xD;
      Magnetic Resonance Spectroscopic Imaging of the CNS will be evaluated at 1.5 and/or at 4.0&#xD;
      Tesla on normal volunteers and in patients with CNS pathology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 1997</start_date>
  <completion_date>July 2003</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>450</enrollment>
  <condition>Healthy</condition>
  <condition>Nervous System Disease</condition>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:&#xD;
&#xD;
        Any normal volunteer age 18 and over who is capable of giving informed consent.&#xD;
&#xD;
        For the purposes of evaluating new techniques for fMRI, patients will be considered the&#xD;
        same as volunteers.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
        A subject will be excluded if he/she has a contraindication to MR scanning such as the&#xD;
        following: aneurysm clip; implanted neural stimulator; implanted cardiac pacemaker or&#xD;
        autodefibrillator; cochlear implant; ocular foreign body or implant (e.g., metal shavings,&#xD;
        retinal clips); breast implants or Insulin pump.&#xD;
&#xD;
        Subjects who have a history of a reaction to MR contrast agents specifically gadopentetate&#xD;
        dimeglumine will be excluded from participating in the contrast agent administration part&#xD;
        of this protocol. The contraindications to MRI at 1.5 Tesla and 4 Tesla are identical.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Warren G. Magnuson Clinical Center (CC)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mattay VS, Frank JA, Santha AK, Pekar JJ, Duyn JH, McLaughlin AC, Weinberger DR. Whole-brain functional mapping with isotropic MR imaging. Radiology. 1996 Nov;201(2):399-404. doi: 10.1148/radiology.201.2.8888231.</citation>
    <PMID>8888231</PMID>
  </reference>
  <reference>
    <citation>Duyn JH, Yang Y, Frank JA, Mattay VS, Hou L. Functional magnetic resonance neuroimaging data acquisition techniques. Neuroimage. 1996 Dec;4(3 Pt 3):S76-83. doi: 10.1006/nimg.1996.0057.</citation>
    <PMID>9345531</PMID>
  </reference>
  <reference>
    <citation>Sorensen AG, Tievsky AL, Ostergaard L, Weisskoff RM, Rosen BR. Contrast agents in functional MR imaging. J Magn Reson Imaging. 1997 Jan-Feb;7(1):47-55. doi: 10.1002/jmri.1880070108.</citation>
    <PMID>9039593</PMID>
  </reference>
  <verification_date>July 2003</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Central Nervous System</keyword>
  <keyword>Technical Development</keyword>
  <keyword>Activation Studies</keyword>
  <keyword>Pulse Sequences</keyword>
  <keyword>Metabolites</keyword>
  <keyword>Normal Volunteer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

